Christopher Turner
Chief Tech/Sci/R&D Officer at NUVALENT, INC.
Net worth: 4 M $ as of 30/03/2024
Christopher Turner active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NUVALENT, INC. | Chief Tech/Sci/R&D Officer | 28/02/2021 | - |
Career history of Christopher Turner
Former positions of Christopher Turner
| Companies | Position | Start | End |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Corporate Officer/Principal | 31/05/2018 | 28/02/2021 |
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | 30/06/2014 | 30/04/2018 |
| ARIAD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - | - |
The Children's Hospital Corp.
 The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Children's Hospital Corp. engages in the provision of pediatric care services. It offers acupuncture, angioplasty, antibiotic allergy testing, audiogram, baclofen pump, biochemical genetic testing, blended diet, bone scan, brain scan, breast augmentation surgery, cardiac catheterization, cardiac MRI in children, chest reconstruction surgery, and CO2 laser treatment. The company was founded by Francis Henry Brown in 1869 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Training of Christopher Turner
| Bowdoin College | Undergraduate Degree |
| University of Rochester School of Medicine & Dentistry | Doctorate Degree |
Statistics
International
| United States | 9 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Health Services | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| CELLDEX THERAPEUTICS, INC. | Health Services |
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| NUVALENT, INC. | Health Technology |
| Private companies | 3 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
The Children's Hospital Corp.
The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Children's Hospital Corp. engages in the provision of pediatric care services. It offers acupuncture, angioplasty, antibiotic allergy testing, audiogram, baclofen pump, biochemical genetic testing, blended diet, bone scan, brain scan, breast augmentation surgery, cardiac catheterization, cardiac MRI in children, chest reconstruction surgery, and CO2 laser treatment. The company was founded by Francis Henry Brown in 1869 and is headquartered in Boston, MA. | Health Services |
- Stock Market
- Insiders
- Christopher Turner
- Experience
